Declining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial: response to O’Hagan et al.

dc.contributor.author	Grobler, Anna Christina.
dc.contributor.author	Abdool Karim, Salim Safurdeen.
dc.date.accessioned	2013-06-25T07:34:44Z
dc.date.available	2013-06-25T07:34:44Z
dc.date.created	2012
dc.date.issued	2012
dc.description.abstract	No abstract available.	en
dc.identifier.citation	Grobler, A., Abdool Karim, S.S. 2012. Declining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial: response to O’Hagan et al. AIDS 26 (17) p.2261.	en
dc.identifier.issn	0269-9370
dc.identifier.uri	http://dx.doi.org/10.1097/QAD.0b013e328355ce08	en
dc.identifier.uri	http://hdl.handle.net/10413/9195
dc.language.iso	en	en
dc.publisher	Lippincott Williams & Wilkins.	en
dc.subject	Clinical trials--Evaluation.	en
dc.subject	HIV infections--Treatment.	en
dc.subject	HIV infections--Drug therapy.	en
dc.subject	Patient compliance.	en
dc.subject.other	CAPRISA 004 microbicide trial.	en
dc.subject.other	Drug adherence.	en
dc.title	Declining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial: response to O’Hagan et al.	en
dc.type	Peer reviewed journal article	en

Files

Now showing 1 - 1 of 1

Now showing 1 - 1 of 1